Drug discovery > Target Discovery Products & Reviews

Xeno-free, serum-free stem cell culture media designed to support the growth and expansion of undifferentiated human embryonic stem cells (hESC), and human induced pluripotent stem cells (hiPSC).  

Serum-free, xeno-free media for the efficient and reproducible differentiation of human mesenchymal stem cells to osteogenic, adipogenic, and chondrogenic lineages. The MSCgo™ family of differentiation media is complete and ready-to-use with optimized differentiation protocols.

Our high performing HEK media are designed to best fit with the high variability of HEK293 cell lines, the versatility of AAV and complexity of viral vector processes from early clinical phases to large commercial scale.  

Sartorius has developed a portfolio of high quality & high performance serum-free, non-animal origin and chemically defined cell culture formulations for CHO cell lines.

Animal-free recombinant cytokines for the efficient and reproducible activation, expansion, and differentiation of human cells. These raw and ancillary materials are widely used in the field of cell and gene therapy as well as regenerative medicine.

A chemically defined, animal component-free, protein-free cryopreservation solution.

A chemically defined, animal component-free, protein-free, phenol red-free cryopreservation solution.

A salt-based, chemically defined, animal component-free, protein-free cryopreservation solution. Contains 5% DMSO.

Enables storage and shipping of cells at non-frozen temperatures without compromising their stability. NutriStor® is an animal component-free (ACF), protein-free solution designed for short-term storage of highly sensitive cells at 2-8ºC during clinical applications and procedures, clinical trials, and cell shipment.

Sartobind® Rapid A is provided as ready-to-use devices which will be fully utilized within a single batch and afterwards disposed: >150 g/L*h productivity, >30 g/L DBC 10% at 12 sec RT, Average cycle times of only 10-15 min.

Flexel® 3D single-use bags for Palletank® are designed for the processing and storage of large volumes of biopharmaceuticals fluids in Palletank® containers. They are available in a range of sizes from 50 L to 1000 L (custom sizes available upon request).

The Palletank ® for shipping was specifically developed for the secure and convenient shipment of bulk pharmaceutical fluids. It is available in volumes of 100L, 200L, and 500L. The associated shipping kit must be purchased along with the Palletank ® container for the system to be complete.

Flexel® Bags for Magnetic Mixer provide a fast dissolution of media powders and an efficient mixing of high concentration buffers or viscous products.

LiquidPlex panel is an advanced and user-friendly research assay for targeted next generation sequencing of circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA) from 28 genes commonly associated with solid tumor type cancers.

FusionPlex Lung v2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 17 genes associated with NSCLC.

FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.

FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.

FusionPlex Pan Solid V2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 137 genes associated with various solid tumor malignancies.

VariantPlex Solid Tumor Focus V2 is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 20 genes associated with various solid tumor malignancies.

VariantPlex Core Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 60 genes associated with various solid tumor malignancies.

VariantPlex Expanded Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 76 genes associated with various solid tumor malignancies.

VariantPlex Pan Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 185 genes associated with various solid tumor malignancies.

VariantPlex Complete Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 430 genes associated with various solid tumor malignancies.

Immunoverse is a research assay that characterizes the immune repertoire, including assessment of T- and B-cell clonalities and rare clones, and detection of tumor infiltrating lymphocytes (TIL) and somatic hypermutation with targeted NGS of key T cell receptor and B cell receptor chain RNA relevant for blood cancer and solid tumor research.

VariantPlex Myeloid is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and ITDs from 75 genes associated with acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS).